HEMEX AG
Desconocido
Embryospin: Increasing in vitro fertilization success rate by turning embryo analysis from qualitative to quanti...
HEMEX AG
participó en un
H2020:
H2020-EIC-SMEInst-2018-2020
EmbryoSpin is a proprietary sensor for μNMR, capable to increase the sensitivity by an order of magnitude (10x) with respect to the state-of...
2021-04-29 - 2023-03-31 | Financiado
2021-04-29 - 2023-03-31 | Financiado
SAFE-CAB: Laser Assisted Surgical System to Revolutionize Cardiac Bypass Surgeries
HEMEX AG
participó en un
H2020:
H2020-EIC-FTI-2018-2020
Coronary Artery Bypass (CAB) surgery is performed annually in >700,000 patients to treat coronary artery disease and
prevent myocardial infa...
2019-10-10 - 2023-06-30 | Financiado
2019-10-10 - 2023-06-30 | Financiado
* No se disponen de datos de la empresa actual.